MANNING MEREDITH (Chief Commercial Officer) sold 10.4% of their position (7.52K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $229.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/31/2026ACC: 0001752631-26-000002
Officer· Chief Commercial Officer
Since Apr 2024
-7.52K
Net shares
Net seller
$229.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.52K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.86K
Price / share
$30.04
Trade value
$146.10K
% of position
6.8%
3/27/2026
72.03K→67.17K
Common Stock
Direct
Shares
−2.10K
Price / share
$31.04
Trade value
$65.18K
% of position
3.1%
3/27/2026
67.17K→65.06K
Common Stock
Direct
Shares
−558.00
Price / share
$31.72
Trade value
$17.70K
% of position
0.9%
3/27/2026
65.06K→64.51K
Total
Net shares
−7.52K
Net value
-$228.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2026 | S · Sale | −4.86K | $30.04 | $146.10K | 6.8% | 72.03K | 67.17K |
| Common Stock Direct | 3/27/2026 | S · Sale | −2.10K | $31.04 | $65.18K | 3.1% | 67.17K | 65.06K |
| Common Stock Direct | 3/27/2026 | S · Sale | −558.00 | $31.72 | $17.70K | 0.9% | 65.06K | 64.51K |
| Total | −7.52K | -$228.98K | ||||||
Derivative Transactions0
No derivative transactions reported